Disparities in the gut metabolome of post-operative Hirschsprung's disease patients

Abstract Hirschsprung's disease (HD) is a congenital structural abnormality of the colon seen in approximately 1 to 5000 live births. Despite surgical correction shortly after presentation, up to 60% of patients will express long-term gastrointestinal complaints, including potentially life-thre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vera Plekhova, Ellen De Paepe, Katrien Van Renterghem, Myriam Van Winckel, Lieselot Y. Hemeryck, Lynn Vanhaecke
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/532c0cc81a17457fbe5a8aebda259ae4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:532c0cc81a17457fbe5a8aebda259ae4
record_format dspace
spelling oai:doaj.org-article:532c0cc81a17457fbe5a8aebda259ae42021-12-02T19:06:40ZDisparities in the gut metabolome of post-operative Hirschsprung's disease patients10.1038/s41598-021-95589-02045-2322https://doaj.org/article/532c0cc81a17457fbe5a8aebda259ae42021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95589-0https://doaj.org/toc/2045-2322Abstract Hirschsprung's disease (HD) is a congenital structural abnormality of the colon seen in approximately 1 to 5000 live births. Despite surgical correction shortly after presentation, up to 60% of patients will express long-term gastrointestinal complaints, including potentially life-threatening Hirschsprung-associated enterocolitis (HAEC). In this study fecal samples from postoperative HD patients (n = 38) and their healthy siblings (n = 21) were analysed using high-resolution liquid chromatography—mass spectrometry aiming to further unravel the nature of the chronic gastrointestinal disturbances. Furthermore, within the patient group, we compared the faecal metabolome between patients with and without a history of HAEC as well as those diagnosed with short or long aganglionic segment. Targeted analysis identified several individual metabolites characteristic for all HD patients as well as those with a history of HAEC and long segment HD. Moreover, multivariate models based on untargeted data established statistically significant (p < 0.05) differences in comprehensive faecal metabolome in the patients’ cohort as a whole and in patients with a history of HAEC. Pathway analysis revealed the most impact on amino sugar, lysine, sialic acid, hyaluronan and heparan sulphate metabolism in HD, as well as impaired tyrosine metabolism in HAEC group. Those changes imply disruption of intestinal mucosal barrier due to glycosaminoglycan breakdown and dysbiosis as major metabolic changes in patients’ group and should be further explored for potential diagnostic or treatment targets.Vera PlekhovaEllen De PaepeKatrien Van RenterghemMyriam Van WinckelLieselot Y. HemeryckLynn VanhaeckeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Vera Plekhova
Ellen De Paepe
Katrien Van Renterghem
Myriam Van Winckel
Lieselot Y. Hemeryck
Lynn Vanhaecke
Disparities in the gut metabolome of post-operative Hirschsprung's disease patients
description Abstract Hirschsprung's disease (HD) is a congenital structural abnormality of the colon seen in approximately 1 to 5000 live births. Despite surgical correction shortly after presentation, up to 60% of patients will express long-term gastrointestinal complaints, including potentially life-threatening Hirschsprung-associated enterocolitis (HAEC). In this study fecal samples from postoperative HD patients (n = 38) and their healthy siblings (n = 21) were analysed using high-resolution liquid chromatography—mass spectrometry aiming to further unravel the nature of the chronic gastrointestinal disturbances. Furthermore, within the patient group, we compared the faecal metabolome between patients with and without a history of HAEC as well as those diagnosed with short or long aganglionic segment. Targeted analysis identified several individual metabolites characteristic for all HD patients as well as those with a history of HAEC and long segment HD. Moreover, multivariate models based on untargeted data established statistically significant (p < 0.05) differences in comprehensive faecal metabolome in the patients’ cohort as a whole and in patients with a history of HAEC. Pathway analysis revealed the most impact on amino sugar, lysine, sialic acid, hyaluronan and heparan sulphate metabolism in HD, as well as impaired tyrosine metabolism in HAEC group. Those changes imply disruption of intestinal mucosal barrier due to glycosaminoglycan breakdown and dysbiosis as major metabolic changes in patients’ group and should be further explored for potential diagnostic or treatment targets.
format article
author Vera Plekhova
Ellen De Paepe
Katrien Van Renterghem
Myriam Van Winckel
Lieselot Y. Hemeryck
Lynn Vanhaecke
author_facet Vera Plekhova
Ellen De Paepe
Katrien Van Renterghem
Myriam Van Winckel
Lieselot Y. Hemeryck
Lynn Vanhaecke
author_sort Vera Plekhova
title Disparities in the gut metabolome of post-operative Hirschsprung's disease patients
title_short Disparities in the gut metabolome of post-operative Hirschsprung's disease patients
title_full Disparities in the gut metabolome of post-operative Hirschsprung's disease patients
title_fullStr Disparities in the gut metabolome of post-operative Hirschsprung's disease patients
title_full_unstemmed Disparities in the gut metabolome of post-operative Hirschsprung's disease patients
title_sort disparities in the gut metabolome of post-operative hirschsprung's disease patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/532c0cc81a17457fbe5a8aebda259ae4
work_keys_str_mv AT veraplekhova disparitiesinthegutmetabolomeofpostoperativehirschsprungsdiseasepatients
AT ellendepaepe disparitiesinthegutmetabolomeofpostoperativehirschsprungsdiseasepatients
AT katrienvanrenterghem disparitiesinthegutmetabolomeofpostoperativehirschsprungsdiseasepatients
AT myriamvanwinckel disparitiesinthegutmetabolomeofpostoperativehirschsprungsdiseasepatients
AT lieselotyhemeryck disparitiesinthegutmetabolomeofpostoperativehirschsprungsdiseasepatients
AT lynnvanhaecke disparitiesinthegutmetabolomeofpostoperativehirschsprungsdiseasepatients
_version_ 1718377149608493056